Cullinan Therapeutics, Inc.
CGEM- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001789972
In the last 90 days, Cullinan Therapeutics, Inc. insiders filed 0 open-market purchases and 3 sales; 183 institutions reported holding it in 13F filings for Q2 2026, worth $1.30B in total; no superinvestor holds it.
Q2 2025 vs. Q1 2025
How the institutions holding Cullinan Therapeutics, Inc. changed between Q1 2025 and Q2 2025.
All holders in Q2 2025All holders in Q1 2025
| Measure | Q1 2025 | Of which not filed for Q2 2025 | Q2 2025 | Change |
|---|---|---|---|---|
| Holders | 149 | 1 | 144 | −4 |
| Shares | 64.7M | 158 | 62.6M | −2.06M (−3.2%) |
| Value | $489.6M | $1.20K | $471.4M | −$18.1M (−3.7%) |
1 institution that held it in Q1 2025 haven't filed for Q2 2025 yet. Not filing isn't selling, so the changes leave them out.
New holders (20)
Institutions that held Cullinan Therapeutics, Inc. at the end of Q2 2025 but not at the end of Q1 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Caption Management, LLC | 175,427 | $1.32M | 0.12% |
| Qube Research & Technologies Ltd | 67,119 | $505.4K | 0.00% |
| Ameriprise Financial Inc | 45,292 | $341.0K | 0.00% |
| Man Group plc | 22,341 | $168.2K | 0.00% |
| Tudor Investment Corp Et Al | 22,138 | $166.7K | 0.00% |
| AQR Capital Management LLC | 20,920 | $157.5K | 0.00% |
| Wexford Capital LP | 18,726 | $141.0K | 0.04% |
| Engineers Gate Manager LP | 18,124 | $136.5K | 0.00% |
| Squarepoint Ops LLC | 15,008 | $113.0K | 0.00% |
| Massar Capital Management, LP | 13,418 | $101.0K | 0.08% |
| State of Wisconsin Investment Board | 11,173 | $84.1K | 0.00% |
| Y-Intercept (Hong Kong) Ltd | 11,129 | $83.8K | 0.00% |
| Advisor Group Holdings, Inc. | 2,115 | $15.9K | 0.00% |
| Bessemer Group Inc | 436 | $3.00K | 0.00% |
| EverSource Wealth Advisors, LLC | 351 | $2.64K | 0.00% |
| MAI Capital Management | 76 | $573 | 0.00% |
| Parallel Advisors, LLC | 64 | $482 | 0.00% |
| Parkside Financial Bank & Trust | 60 | $452 | 0.00% |
| Essential Partners LLC | 40 | $301 | 0.00% |
| Versant Capital Management, Inc | 23 | $173 | 0.00% |
Sold out (24)
Institutions that held Cullinan Therapeutics, Inc. at the end of Q1 2025 and filed for Q2 2025 without it.
| Institution | Shares, Q1 2025 | Value, Q1 2025 |
|---|---|---|
| Braidwell LP | 980,773 | $7.42M |
| Woodline Partners LP | 81,741 | $618.8K |
| Acadian Asset Management LLC | 81,721 | $618.0K |
| Perceptive Advisors LLC | 80,100 | $606.4K |
| UBS Oconnor LLC | 32,903 | $249.1K |
| Corebridge Financial, Inc. | 25,603 | $193.8K |
| Two Sigma Advisers, LP | 25,100 | $190.0K |
| Dynamic Technology Lab Private Ltd | 21,581 | $163.0K |
| HRT Financial LP | 20,850 | $157.0K |
| SG Americas Securities, LLC | 16,636 | $126.0K |
| Oxford Asset Management LLP | 15,746 | $119.2K |
| Two Sigma Investments, LP | 14,796 | $112.0K |
| Axq Capital, LP | 14,255 | $107.9K |
| Exchange Traded Concepts, LLC | 14,107 | $106.8K |
| Profund Advisors LLC | 11,846 | $89.7K |
| CIBC World Markets Corp | 11,597 | $87.8K |
| Virginia Retirement Systems Et Al | 10,627 | $80.4K |
| Quadrant Capital Group LLC | 2,972 | $22.5K |
| Aquatic Capital Management LLC | 395 | $2.99K |
| Group One Trading, L.P. | 389 | $2.94K |
| Coldstream Capital Management Inc | 207 | $1.57K |
| Amundi | 40 | $300 |
| Massmutual Trust Co FSB | 36 | $273 |
| CoreCap Advisors, LLC | 29 | $220 |
Not filed for Q2 2025 yet (1)
Institutions that held Cullinan Therapeutics, Inc. at the end of Q1 2025 and haven't filed a 13F for Q2 2025. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2025 | Value, Q1 2025 |
|---|---|---|
| Lindbrook Capital, LLC | 158 | $1.20K |